Tumor-Related Immune Checkpoints And The Development Of Targeted Cancer Immunotherapies

"Revisiting the Neoantigen Approach for Cancer Immunotherapy" by Dr. Yardena SamuelsПодробнее

Immuno-oncology: Cold to Hot TumoursПодробнее

Immune Checkpoint Inhibitors, The Next Generation Cancer Therapy - Creative BiolabsПодробнее

5 Current Trends of Cancer Immunotherapy 2022 I Atlantis BioscienceПодробнее

Curing metastatic solid tumours with immune checkpoint inhibitors by Professor James LarkinПодробнее

Stanford Cancer Institute Breakthroughs in Cancer: Luis Diaz, MDПодробнее

Adoptive immunotherapy with tumor-infiltrating T lymphocytes - Simon TurcotteПодробнее

Macrophages as Targets in Cancer Immunotherapy - Creative BiolabsПодробнее

Targeting TIGIT to Extend Immunotherapy Benefits to More Cancer PatientsПодробнее

High-throughput genomics in cancer immunity and immunotherapy by Dr. Ansuman SatpathyПодробнее

Glyco-checkpoints as Therapeutic Targets in Cancer, Autoimmunity & Infection by Dr. G. RabinovichПодробнее

Primary and Acquired Resistance to Cancer ImmunotherapyПодробнее

Renal-Cell-Cancer-Targeting an Immune Checkpoint or Multiple KinassesПодробнее

Beyond anti-PD-1 and anti-CTLA-4 in melanomaПодробнее

Frontiers in Oncology - Antoni Ribas, MD, PhDПодробнее

Immunotherapeutics with Dr. James GulleyПодробнее

James Allison, PhD - Immune Checkpoint Blockade in Cancer Therapy (2020)Подробнее

Keynote Presentation: Development of Rational Immunotherapy Combinations to Overcome the Immuno...Подробнее

Lecture 10c: Cancer ImmunotherapyПодробнее

Targeting Tumor Associated Macrophages in Ovarian CancerПодробнее